Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P H Hilkens

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
British Journal of Cancer|January 1, 1997
Peripheral neuropathy induced by combination chemotherapy of docetaxel and cisplatinP H Hilkens, L C Pronk, J Verweij, et al.
Clinical Neurology and Neurosurgery|May 1, 1995
Effect of an ACTH(4-9) analogue on cisplatin neuropathy of longstanding duration: a phase II studyP H Hilkens, M E van der Burg, J W Moll, et al.
Neurology|March 4, 1998
Lhermitte's sign following chemotherapy with docetaxelM J van den Bent, P H Hilkens, P A Sillevis Smitt, et al.
European Journal of Neurology|November 29, 2013
Clinical course and risk factors of neurotoxicity following cisplatin in an intensive dosing scheduleP H Hilkens, A S Planting, M E van der Burg, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1995
Neurotoxicity is not enhanced by increased dose intensities of cisplatin administrationP H Hilkens, M E van der Burg, J W Moll, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1997
Phase I and pharmacologic study of docetaxel and cisplatin in patients with advanced solid tumorsL C Pronk, J H Schellens, A S Planting, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
British Journal of Cancer|January 1, 1997
Peripheral neuropathy induced by combination chemotherapy of docetaxel and cisplatinP H Hilkens, L C Pronk, J Verweij, et al.
Clinical Neurology and Neurosurgery|May 1, 1995
Effect of an ACTH(4-9) analogue on cisplatin neuropathy of longstanding duration: a phase II studyP H Hilkens, M E van der Burg, J W Moll, et al.
Neurology|March 4, 1998
Lhermitte's sign following chemotherapy with docetaxelM J van den Bent, P H Hilkens, P A Sillevis Smitt, et al.
European Journal of Neurology|November 29, 2013
Clinical course and risk factors of neurotoxicity following cisplatin in an intensive dosing scheduleP H Hilkens, A S Planting, M E van der Burg, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1995
Neurotoxicity is not enhanced by increased dose intensities of cisplatin administrationP H Hilkens, M E van der Burg, J W Moll, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1997
Phase I and pharmacologic study of docetaxel and cisplatin in patients with advanced solid tumorsL C Pronk, J H Schellens, A S Planting, et al.
Pageof 2